Amoxicillin-Potassium Clavulanate Combination

EsbL ; Escherichia coli







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35451880 In Vitro and In Vivo Activity of Amoxicillin-Clavulanate Combined with Ceftibuten or Cefpodoxime Against Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae. 2022 Apr 1
2 35500548 Examining the combination of cefixime and amoxicillin/clavulanate against extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates. 2022 May 2 1
3 33943052 Single-dose amikacin plus 7 days of amoxicillin/clavulanate to treat acute cystitis caused by extended-spectrum beta-lactamase-producing Escherichia coli: A retrospective cohort study. 2021 May 1
4 34795702 Prevalence and antimicrobial susceptibility of extended-spectrum beta lactamases-producing Escherichia coli and Klebsiella pneumoniae isolated in selected hospitals of Anyigba, Nigeria. 2021 Jun 2
5 30117050 Ceftibuten plus amoxicillin-clavulanic acid for oral treatment of urinary tract infections with ESBL producing E. coli and K. pneumoniae: a retrospective observational case-series. 2018 Oct 3
6 30123199 Molecular Characterization of Extended-Spectrum β-Lactamase-Producing Multidrug Resistant Escherichia coli From Swine in Northwest China. 2018 1
7 30532496 Detection, characterization, and antibiogram of extended-spectrum beta-lactamase Escherichia coli isolated from bovine milk samples in West Bengal, India. 2018 Nov 1
8 27973988 Characterisation of extended-spectrum β-lactamase and AmpC β-lactamase-producing Enterobacteriaceae isolated from companion animals in New Zealand. 2017 Mar 1
9 25716293 β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options? 2015 Apr 1
10 25100821 Integrating forecast probabilities in antibiograms: a way to guide antimicrobial prescriptions more reliably? 2014 Oct 1
11 19614715 Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates. 2010 Feb 2
12 15815007 Evaluation and updating of the Osiris expert system for identification of Escherichia coli beta-lactam resistance phenotypes. 2005 Apr 1